Eklosium SRL
Eklosium reported total assets of 21,432 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 May 2026).
The score of Eklosium shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Eklosium's annual accounts
| 2025 | |
|---|---|
| Net result | 6,365 € |
| Equity | 8,865 € |
| Cash | 4,429 € |
| EBITDA | 17,075 € |
| Total assets | 21,432 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 26 May 2026
Eklosium's financial analysis
- Solvency41.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Eklosium
Eklosium's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1016.650.070
- VAT number
- BE1016650070
- Peppol
- Registered · 0208:1016650070 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Nov 2024
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2025 · filed on 26 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Eklosium (SRL) has been based in Schaerbeek since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 6,365 € and equity of 8,865 €; its revenue is not published. Its solvency stands at 41.4%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Eklosium
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Vandyck Retail sale of pharmaceutical products Anderlecht · balance sheet 21,647 €
- Ajaga Retail sale of pharmaceutical products Knokke-Heist · balance sheet 21,992 €
- Kasibel Retail sale of pharmaceutical products Uccle · balance sheet 20,641 €
- JL Pharma Retail sale of pharmaceutical products Stoumont · balance sheet 22,608 €
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Farmaco Retail sale of pharmaceutical products Ranst · balance sheet 17,325 €
Frequently asked questions about Eklosium
What is the revenue of Eklosium?
Eklosium files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Eklosium?
In Belgium, the VAT number is the company number prefixed with BE: BE1016650070 for Eklosium, if the company is VAT-registered. Its company number (CBE) is 1016.650.070.
Where is the registered office of Eklosium?
According to the CBE register, the registered office of Eklosium is in 1030 Schaerbeek.
What is the equity of Eklosium?
At the close of the 2025 financial year, the equity of Eklosium amounts to 8,865 €, a solvency of 41.4% of total assets.
Who manages Eklosium?
The register lists 2 active mandates at Eklosium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Eklosium
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →